GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 209 filers reported holding GENMAB A/S in Q1 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $221,072 | -1.9% | 6,268 | +5.7% | 0.00% | – |
Q2 2023 | $225,437 | +12.0% | 5,931 | +11.3% | 0.00% | – |
Q1 2023 | $201,260 | -14.7% | 5,330 | -4.1% | 0.00% | – |
Q4 2022 | $236,000 | +15.1% | 5,558 | -2.0% | 0.00% | – |
Q1 2022 | $205,000 | -58.5% | 5,669 | -54.6% | 0.00% | – |
Q4 2021 | $494,000 | +93.7% | 12,481 | +113.1% | 0.00% | – |
Q3 2021 | $255,000 | +10.9% | 5,858 | +4.1% | 0.00% | – |
Q2 2021 | $230,000 | -0.9% | 5,626 | -20.1% | 0.00% | – |
Q1 2021 | $232,000 | -84.3% | 7,043 | -80.6% | 0.00% | -100.0% |
Q4 2020 | $1,478,000 | +20.3% | 36,367 | +8.4% | 0.00% | – |
Q3 2020 | $1,229,000 | +502.5% | 33,557 | +459.5% | 0.00% | – |
Q2 2020 | $204,000 | -77.1% | 5,998 | -85.7% | 0.00% | – |
Q1 2020 | $891,000 | -3.3% | 42,069 | +1.9% | 0.00% | – |
Q4 2019 | $921,000 | +11.4% | 41,273 | +1.0% | 0.00% | – |
Q3 2019 | $827,000 | +9088.9% | 40,852 | +9080.2% | 0.00% | – |
Q3 2014 | $9,000 | +200.0% | 445 | +256.0% | 0.00% | – |
Q2 2014 | $3,000 | +50.0% | 125 | +7.8% | 0.00% | – |
Q1 2014 | $2,000 | – | 116 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |